-
Study aim
-
The effect of Wheat Germ consumption on anthropometric indices, lipid profiles, glycemic status, hepatic enzymes, hepatocyte apoptosis (Cytokeratin-18), inflammatory factors, total antioxidant capacity and liver fibrosis in non-alcoholic fatty liver patients
-
Design
-
Randomized clinical trials with control groups, parallel group are performed on 42 patients
-
Settings and conduct
-
In this study, adults with non-alcoholic fatty liver disease referred to liver clinic of Taleghani hospital, who have the criteria to enter the study, if they desire to participate in this research fill out general and activity questionnaires and anthropometric indicators are collected. At the beginning and end of the study, fibroscan and blood tests are performed to evaluate the indicators
-
Participants/Inclusion and exclusion criteria
-
People who desire to participate in the study; age 18-50 years; BMI above 25 who have evidence of non-alcoholic steatohepatitis in ultrasound or fibroscan; no history of alcohol consumption or alcohol consumption less than 10 grams per day in women and less than 20 grams per day in men; absence of other chronic and acute liver diseases and disorders, biliary tract disease, autoimmune diseases, cancer and hereditary disorders affecting Liver status and liver cirrhosis, lack of pregnancy or lactation in women; no use of hepatotoxic drugs are included in the study. If they do not want to continue studying or using hepatotoxic drugs during the study or non-compliance with the diet, they are excluded.
-
Intervention groups
-
1- Control 2-wheat germ
-
Main outcome variables
-
Hepatic fibrosis, and steatosis Lipid profile, Glycemic indices, Liver enzymes, Inflammatory factors